Chromosomes humains de la paire 3 : Questions médicales fréquentes
Nom anglais: Chromosomes, Human, Pair 3
Descriptor UI:D002893
Tree Number:G05.360.162.520.300.235.250
Termes MeSH sélectionnés :
Research Design
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes humains de la paire 3 : Questions médicales les plus fréquentes",
"headline": "Chromosomes humains de la paire 3 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chromosomes humains de la paire 3 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-04",
"dateModified": "2025-04-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chromosomes humains de la paire 3"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Chromosomes humains 1-3",
"url": "https://questionsmedicales.fr/mesh/D002900",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes humains 1-3",
"code": {
"@type": "MedicalCode",
"code": "D002900",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.162.520.300.235"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes humains de la paire 3",
"alternateName": "Chromosomes, Human, Pair 3",
"code": {
"@type": "MedicalCode",
"code": "D002893",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hoa H Chuong",
"url": "https://questionsmedicales.fr/author/Hoa%20H%20Chuong",
"affiliation": {
"@type": "Organization",
"name": "Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA."
}
},
{
"@type": "Person",
"name": "Arang Rhie",
"url": "https://questionsmedicales.fr/author/Arang%20Rhie",
"affiliation": {
"@type": "Organization",
"name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA."
}
},
{
"@type": "Person",
"name": "Sergey Koren",
"url": "https://questionsmedicales.fr/author/Sergey%20Koren",
"affiliation": {
"@type": "Organization",
"name": "Genome Informatics Section, Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA."
}
},
{
"@type": "Person",
"name": "Erik Garrison",
"url": "https://questionsmedicales.fr/author/Erik%20Garrison",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA."
}
},
{
"@type": "Person",
"name": "Jennifer L Gerton",
"url": "https://questionsmedicales.fr/author/Jennifer%20L%20Gerton",
"affiliation": {
"@type": "Organization",
"name": "Stowers Institute for Medical Research, Kansas City, MO, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Training needs of health researchers in research ethics in Cameroon: a cross-sectional study.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36175947",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12909-022-03767-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reflections on the use of FPAR as a research methodology for sex worker (and key populations) research.",
"datePublished": "2022-09-01",
"url": "https://questionsmedicales.fr/article/36050825",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/17441692.2022.2110915"
}
},
{
"@type": "ScholarlyArticle",
"name": "Research-Problem Validity in Primary Research: Precision and Transparency in Characterizing Past Knowledge.",
"datePublished": "2023-02-06",
"url": "https://questionsmedicales.fr/article/36745743",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/17456916221144990"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pragmatic clinical trial design in emergency medicine: Study considerations and design types.",
"datePublished": "2022-05-22",
"url": "https://questionsmedicales.fr/article/35475533",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/acem.14513"
}
},
{
"@type": "ScholarlyArticle",
"name": "RESTART trial design: two-stage seamless transition design with operational considerations.",
"datePublished": "2023-01-18",
"url": "https://questionsmedicales.fr/article/36653753",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/10543406.2022.2162915"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Chromosomes",
"item": "https://questionsmedicales.fr/mesh/D002875"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chromosomes de mammifère",
"item": "https://questionsmedicales.fr/mesh/D033481"
},
{
"@type": "ListItem",
"position": 6,
"name": "Chromosomes humains",
"item": "https://questionsmedicales.fr/mesh/D002877"
},
{
"@type": "ListItem",
"position": 7,
"name": "Chromosomes humains 1-3",
"item": "https://questionsmedicales.fr/mesh/D002900"
},
{
"@type": "ListItem",
"position": 8,
"name": "Chromosomes humains de la paire 3",
"item": "https://questionsmedicales.fr/mesh/D002893"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chromosomes humains de la paire 3 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chromosomes humains de la paire 3",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chromosomes humains de la paire 3",
"description": "Comment diagnostiquer une anomalie du chromosome 3 ?\nQuels tests génétiques sont utilisés pour le chromosome 3 ?\nQuels signes indiquent un problème avec le chromosome 3 ?\nLes échographies peuvent-elles détecter des anomalies chromosomiques ?\nQuel rôle joue le conseil génétique dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chromosomes humains de la paire 3",
"description": "Quels symptômes sont associés aux anomalies du chromosome 3 ?\nLes anomalies du chromosome 3 affectent-elles le développement physique ?\nY a-t-il des symptômes neurologiques liés au chromosome 3 ?\nLes troubles du comportement sont-ils fréquents ?\nLes anomalies du chromosome 3 peuvent-elles causer des problèmes cardiaques ?",
"url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chromosomes humains de la paire 3",
"description": "Peut-on prévenir les anomalies chromosomiques ?\nQuel rôle joue la santé maternelle dans la prévention ?\nLes tests prénataux peuvent-ils prévenir des anomalies ?\nL'éducation génétique est-elle importante ?\nLes vaccinations peuvent-elles prévenir des anomalies ?",
"url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chromosomes humains de la paire 3",
"description": "Quels traitements sont disponibles pour les anomalies du chromosome 3 ?\nLa chirurgie est-elle une option pour les malformations ?\nLes médicaments peuvent-ils aider les symptômes ?\nComment la thérapie comportementale aide-t-elle ?\nY a-t-il des traitements spécifiques pour les retards de développement ?",
"url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chromosomes humains de la paire 3",
"description": "Quelles complications peuvent survenir avec des anomalies du chromosome 3 ?\nLes anomalies chromosomiques augmentent-elles le risque de cancer ?\nY a-t-il des complications psychologiques ?\nLes complications affectent-elles la qualité de vie ?\nLes soins de santé sont-ils plus complexes ?",
"url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chromosomes humains de la paire 3",
"description": "Quels sont les facteurs de risque pour les anomalies du chromosome 3 ?\nL'exposition à des toxines influence-t-elle les anomalies ?\nLes maladies génétiques familiales sont-elles un facteur ?\nLe mode de vie peut-il affecter les risques ?\nLes infections pendant la grossesse sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D002893?mesh_terms=Research+Design&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie du chromosome 3 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un caryotype ou des tests génétiques spécifiques peuvent révéler des anomalies."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont utilisés pour le chromosome 3 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de microdélétion et les analyses de SNP sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème avec le chromosome 3 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des retards de développement ou des malformations peuvent indiquer des anomalies."
}
},
{
"@type": "Question",
"name": "Les échographies peuvent-elles détecter des anomalies chromosomiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies peuvent être suspectées lors des échographies prénatales."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le conseil génétique dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le conseil génétique aide à interpréter les résultats et à évaluer les risques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux anomalies du chromosome 3 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des retards mentaux, des malformations et des troubles du comportement."
}
},
{
"@type": "Question",
"name": "Les anomalies du chromosome 3 affectent-elles le développement physique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des malformations physiques et des problèmes de croissance."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques liés au chromosome 3 ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent causer des troubles neurologiques comme l'épilepsie."
}
},
{
"@type": "Question",
"name": "Les troubles du comportement sont-ils fréquents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles du comportement peuvent être observés chez les personnes affectées."
}
},
{
"@type": "Question",
"name": "Les anomalies du chromosome 3 peuvent-elles causer des problèmes cardiaques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies sont associées à des malformations cardiaques congénitales."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies chromosomiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies ne peuvent pas être prévenues, mais le conseil génétique aide."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la santé maternelle dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne santé maternelle avant et pendant la grossesse peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les tests prénataux peuvent-ils prévenir des anomalies ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils permettent de détecter des anomalies, mais ne les préviennent pas."
}
},
{
"@type": "Question",
"name": "L'éducation génétique est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle aide les familles à comprendre les risques et les options disponibles."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir des anomalies ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas les anomalies chromosomiques, mais protègent la santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les anomalies du chromosome 3 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend des symptômes et peut inclure thérapies physiques et éducatives."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option pour les malformations ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être nécessaire pour corriger certaines malformations physiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider les symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour gérer des symptômes comme l'épilepsie."
}
},
{
"@type": "Question",
"name": "Comment la thérapie comportementale aide-t-elle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut améliorer les compétences sociales et réduire les comportements problématiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements spécifiques pour les retards de développement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes d'intervention précoce peuvent aider à améliorer le développement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies du chromosome 3 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des problèmes de santé chroniques et des retards."
}
},
{
"@type": "Question",
"name": "Les anomalies chromosomiques augmentent-elles le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent être associées à un risque accru de certains cancers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications psychologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles psychologiques peuvent survenir, nécessitant un suivi."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent avoir un impact significatif sur la qualité de vie des individus."
}
},
{
"@type": "Question",
"name": "Les soins de santé sont-ils plus complexes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des anomalies chromosomiques peuvent nécessiter des soins spécialisés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies du chromosome 3 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge maternel avancé et des antécédents familiaux augmentent les risques."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines influence-t-elle les anomalies ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines pendant la grossesse peut augmenter les risques."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques familiales sont-elles un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies génétiques peuvent augmenter le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire certains risques d'anomalies chromosomiques."
}
},
{
"@type": "Question",
"name": "Les infections pendant la grossesse sont-elles un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent augmenter le risque d'anomalies chromosomiques."
}
}
]
}
]
}
Researchers are responsible for the protection of health research participants. The purpose of this study was to identify and prioritize the training needs of researchers involved in human health rese...
It was a cross-sectional study conducted in all the Cameroon regions in the last quarter of 2020. It targeted researchers involved in human health research selected by systematic stratified sampling f...
Of 168 reached participants, 134 (79.76%) participated in the study. A total of 103 (76.87%) researchers reported having received training in human health research ethics and 98 (73.13%) perceived nee...
The coverage of researchers in training regarding research participant protection remains limited in a number of areas including those related to clinical trial participant protection and research par...
Four validity types evaluate the approximate truth of inferences communicated by primary research. However, current validity frameworks ignore the truthfulness of empirical inferences that are central...
Pragmatic clinical trials (PCTs) focus on correlation between treatment and outcomes in real-world clinical practice, yet a guide highlighting key study considerations and design types for emergency m...
Oncology/hematology is a competitive therapeutic area where the landscape is constantly evolving. With regulatory support, many drug developers have spent a lot of resources on the operationalization ...
Clinical trial designs based on the assumption of independent observations are well established. Clustered clinical trial designs, where all observational units belong to a cluster and outcomes within...
In this article, we present an overarching definition of partially clustered trials, bringing together several existing trial designs including those for group-based treatments, clustering due to faci...
Our findings demonstrate that the description of these trials is often incomplete and the terminology used to describe the trial designs is inconsistent, restricting the ability to identify these tria...
Cell-free protein synthesis has been widely used as a "breadboard" for design of synthetic genetic networks. However, due to a severe lack of modularity, forward engineering of genetic networks remain...
Using the example of a psychological research project in the Andean context, this explorative interview study adds to the current debate about ethical challenges of psychological cross-cultural resear...
Meta-epidemiological research plays a vital role in providing empirical evidence needed to develop methodological manuals and tools, but the reporting quality has not been comprehensively assessed, an...
We searched PubMed and Embase for meta-epidemiological studies. The reporting quality of these studies was assessed for adherence to established reporting guidelines. Two researchers independently scr...
We initially identified 1720 articles, of which 125 meta-epidemiological studies met the inclusion criteria. Of these, 65 (52%) had low reporting quality, 60 (48%) had moderate quality, and none achie...
Our analysis showed suboptimal reporting quality in meta-epidemiological studies, with no improvement post-2017 guidelines. This potential shortcoming could hinder stakeholders' ability to draw reliab...
The San Francisco Declaration on Research Assessment (DORA) advocates for assessing biomedical research quality and impact, yet academic organizations continue to employ traditional measures such as J...
We conducted a review of published and grey literature to identify measures of research quality and impact, which we included in an online survey. We assembled a panel of researchers and research lead...
We identified 50 measures organized in 8 domains: relevance of the research program, challenges to research program, or productivity, team/open science, funding, innovations, publications, other disse...
Our work contributes to the field by identifying 10 DORA-compliant measures of research quality and impact, a more comprehensive and explicit set of measures than prior efforts. Research is needed to ...